Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Collaborations to Enhance Drug Development and Regulatory Science

    Forecasted

    FDA grant supports collaborative projects to advance drug development, manufacturing, and regulatory science, focusing on safety, efficacy, and innovation.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Critical Path Public Private Partnerships Clinical Trials Optional

    The FDA seeks applications to maintain and manage existing research consortia established by the Critical Path Institute to foster drug innovation and development.

    HHS-FDA$20,000,000Forecasted

    Flexible Funding Model - Advancing Domestic Mutual Reliance Through Strengthened Infrastructure Development and Maintenance for Manufactured Food Regulatory Programs

    FDA funding helps manufactured food regulatory programs build and maintain infrastructure, meet national standards, and strengthen shared food safety oversight through collaboration and data sharing.

    HHS-FDADue Dec 14, 2026$2,175,000Newly Listed

    Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed

    This grant funds state programs to fully implement and maintain animal food safety standards and strengthen collaboration with the FDA for a nationally integrated and mutually reliant food safety system.

    HHS-FDADue Mar 1, 2027$1,800,000Limited submission

    Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials Not Allowed

    This grant funds state programs to improve food safety through infrastructure development, maintenance, and special projects related to manufactured food, dietary supplements, and task forces.

    HHS-FDA$1,285,000Forecasted

    Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)

    FDA grant seeks research to reduce nitrosamine impurities in drugs, ensuring public safety and continued access to needed medications, with a plan for sustained research.

    HHS-FDA$350,000Forecasted